Concepedia

Weiya Cao

WC

12

Publications

332

Citations

12

H-Index

2019

Active since

Affiliations

Anhui University of Science and Technology(Current)

Guangzhou Medical University

First Affiliated Hospital of Bengbu Medical College

Jinan University

Weiya Cao is an author at Anhui University of Science and Technology specializing in cell biology, cancer biology, and medicine.

ORCID

Top concepts

Publications per year

2019–2022

12

Publications

12

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li et al. · PubMed · 2019 · 44 citations · Full text

, , +17

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li et al. · Toxicology Mechanisms and Methods · 2021 · 40 citations

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu et al. · International Journal of Medical Sciences · 2021 · 36 citations · Full text

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang et al. · PubMed · 2019 · 32 citations · Full text

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway

Ruyue Xu, Yinci Zhang, Amin Li et al. · Molecular Medicine Reports · 2021 · 30 citations · Full text

, , +18

Rows per page

1–5 of 12